Norsk Hydro
President & CEO, Hilde Merete Aasheim, will present the transaction by an audio webcast and a conference call, in English, at 09:00 CET today, Friday 5 March.
In order to listen to the presentation, please join the audio webcast. There will be a Q&A session directly after the presentation. If you would like to ask questions, you need to join the conference call before end of the presentation. Please see details below. It will not be possible to ask questions on the audio webcast.
To join the conference call, please use the below "Click to Join" link 5-10 minutes prior to start time. You will be asked to enter your phone number and registration details. The Event Conferencing system will call you on the phone number you provide and place you into the event. Please note that the "Click to Join" link becomes active 15 minutes prior to the scheduled start time.
Please use the "Click to Join" option for the easiest way to join the conference call.
Click to Join Call 09:00 CET >>
As an alternative, use the dial-in numbers below for the conference call:
Norway +47 2100 2613
UK +44 (0)330 336 9104
USA +1 323-794-2442
Sweden +46 (0)8 5033 6573
Brazil +55 11 3181 5319
Germany +49 (0)89 2030 31236
Participant Passcode: 129096
Contact details:
Investor contact:
Line Haugetraa
+47 41406376
Media contact:
Halvor Molland
+47 92979797
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd8.11.2025 00:00:00 CET | Press release
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
Columbus A/S7.11.2025 23:46:30 CET | Press release
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Evaxion7.11.2025 23:10:00 CET | Press release
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
VALLOUREC7.11.2025 18:45:00 CET | Press release
VALLOUREC ANNOUNCES A TRANSITION IN ITS FINANCIAL MANAGEMENT
Trifork Group AG7.11.2025 18:29:08 CET | Press release
52/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
